FLIP (CFLAR) Human shRNA Plasmid Kit (Locus ID 8837)
CAT#: TR313960
CFLAR - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 3 publications. |
Product images
经常一起买 (2)
CFLAR mouse monoclonal antibody, clone OTI2H8 (formerly 2H8)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | FLIP (CFLAR) Human shRNA Plasmid Kit (Locus ID 8837) |
Locus ID | 8837 |
UniProt ID | O15519 |
Synonyms | c-FLIP; c-FLIPL; c-FLIPR; c-FLIPS; CASH; CASP8AP1; Casper; cFLIP; CLARP; FLAME; FLAME-1; FLAME1; FLIP; I-FLICE; MRIT |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | CFLAR - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 8837). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_001127183, NM_001127184, NM_001202515, NM_001202516, NM_001202517, NM_001202518, NM_001202519, NM_001308042, NM_001308043, NM_003879, NM_001351590, NM_001351591, NM_001351592, NM_001351593, NM_001351594, NR_147241, NR_147242, NR_147243, NR_147244, NR_147245, NR_147246, NR_147247, NR_147248, NR_147249, NR_147250, NR_147251, NR_147252, NR_147253, NR_147255, NM_003879.1, NM_003879.2, NM_003879.3, NM_003879.4, NM_003879.5, NM_001127184.1, NM_001127184.2, NM_001127183.1, NM_001127183.2, NM_001202515.1, NM_001202518.1, NM_001202519.1, NM_001202517.1, NM_001202516.1, BC001602, BC001602.1, BC000801, BM969271, NM_001127183.4, NM_001127184.3, NM_001202518.2, NM_003879.7, NM_001202517.3, NM_001202516.3, NM_001202519.3 |
Summary | The protein encoded by this gene is a regulator of apoptosis and is structurally similar to caspase-8. However, the encoded protein lacks caspase activity and appears to be itself cleaved into two peptides by caspase-8. Several transcript variants encoding different isoforms have been found for this gene, and partial evidence for several more variants exists. [provided by RefSeq, Feb 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (3)
The use of this RNAi has been cited in the following citations: |
---|
Esophageal cancer cells convert the death signal from TRAIL into a stimulus for survival during acid/bile exposure
,Chang, Z;Dang, T;Che, N;Yu, H;Chai, J;Chen, W;,
Digestive and Liver Disease
,PubMed ID 32505571
[CFLAR]
|
TNF Apoptosis Protection Fraction (TAPF) prevents apoptosis induced by TNF, but not by Fas or TRAIL, via NF-?B-induced increase in cFLIP
,Seol, JY;Mihich, E;Berleth, ES;,
Cytokine
,PubMed ID 26198031
[CFLAR]
|
Inhibition of NF-{kappa}B Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin
,Tanvi S. Jani, Jennifer DeVecchio, Tapati Mazumdar, Akwasi Agyeman, and Janet A. Houghton,
J. Biol. Chem., Jun 2010; 285: 19162 - 19172
[CFLAR]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...